CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway: Erratum

Liu, Yan-ming; Cao, Yue; Zhao, Ping-sen; Wu, Liang-yin; Lu, Ya-min; Wang, Yu-long; Zhao, Jia-feng; Liu, Xin-guang

doi:10.7150/ijbs.72651

PDF

Int J Biol Sci 2022; 18(6):2652-2654. doi:10.7150/ijbs.72651 This issue Cite

Erratum

CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway: Erratum

Yan-ming Liu^1,2*, Yue Cao^3,4*, Ping-sen Zhao², Liang-yin Wu², Ya-min Lu², Yu-long Wang⁵, Jia-feng Zhao⁶, Xin-guang Liu¹

1. Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Institute of Aging Research, Guangdong Medical University, Dongguan, Guangdong, China.
2. Department of Clinical Laboratory, YueBei People's Hospital, Shaoguan, Guangdong, China.
3. The Third Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
4. Department of Medical Technology, Medical College of Shaoguan University, Shaogguan, Guangdong, China.
5. Department of Anesthesiology, YueBei People's Hospital, Shaoguan, Guangdong, China.
6. Department of Hepatobiliary Surgery, YueBei People's Hospital, Shaoguan, Guangdong, China.
*These authors contributed equally to this work.

Citation:

Liu Ym, Cao Y, Zhao Ps, Wu Ly, Lu Ym, Wang Yl, Zhao Jf, Liu Xg. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway: Erratum. Int J Biol Sci 2022; 18(6):2652-2654. doi:10.7150/ijbs.72651. https://www.ijbs.com/v18p2652.htm

Other styles

Corrected-article in Int J Biol Sci, Volume 18, 637

Correction 1

In Figure 1A, the number of S1.sheet 15 and S1.sheet 19 was wrong, the correct number was S2.sheet 15 and S2.sheet 19, respectively. The correct picture is displayed below.

Figure A

Corrected original Figure 1A.

Correction 2

In Figure 3F, the sign (*) of significant difference is not marked in the proper position, the correct picture is displayed below.

Figure B

Corrected original Figure 3F.

Correction 3

In Figure 5E, the circCCNB1's picture of HepG2 cell, which did not match the other three pictures (miR-106b-5p, Hoechst, and merged), was misused. The correct picture is displayed below.

Figure C

Corrected original Figure 5E.

Correction 4

In Figure S4E of the Supplementary figures and tables file (S1), the signs (*) of significant difference are not marked in the proper position. The correct picture is displayed below.

Figure D

Corrected original Figure S4E.

Author contact

Corresponding author: Xin-guang Liu, Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Institute of Aging Research, Guangdong Medical University, Dongguan, Guangdong, China. E-mail: xgliuedu.cn.

Published 2022-3-22

Citation styles

APA

Liu, Y.m., Cao, Y., Zhao, P.s., Wu, L.y., Lu, Y.m., Wang, Y.l., Zhao, J.f., Liu, X.g. (2022). CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway: Erratum. International Journal of Biological Sciences, 18(6), 2652-2654. https://doi.org/10.7150/ijbs.72651.

ACS

Liu, Y.m.; Cao, Y.; Zhao, P.s.; Wu, L.y.; Lu, Y.m.; Wang, Y.l.; Zhao, J.f.; Liu, X.g. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway: Erratum. Int. J. Biol. Sci. 2022, 18 (6), 2652-2654. DOI: 10.7150/ijbs.72651.

NLM

CSE

Liu Ym, Cao Y, Zhao Ps, Wu Ly, Lu Ym, Wang Yl, Zhao Jf, Liu Xg. 2022. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway: Erratum. Int J Biol Sci. 18(6):2652-2654.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.